SCHEMBL9724536

SCHEMBL9724536

CC(C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)C=Cc1ccccc1)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.51
ALDH1A1 P00352 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C9 P11712 1/20 0.49
MAPK1 P28482 1/20 0.49
CYP2C19 P33261 1/20 0.49
PPARG P37231 1/20 0.45
NOS2 P35228 3/20 0.45
CASP1 P29466 1/20 0.44
CASP3 P42574 1/20 0.44
CASP7 P55210 1/20 0.44
CASP6 P55212 1/20 0.44
CASP8 Q14790 1/20 0.44
HTRA1 Q92743 4/20 0.44
LMNA P02545 2/20 0.43
MME P08473 1/20 0.43
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7325542 0.88 HDAC1 (0.44) ALDH1A1NOS2HDAC3HDAC4HDAC1
SCHEMBL7425727 0.84 TDP1 (0.65) TDP1ALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL7425739 0.84 TDP1 (0.65) TDP1ALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL7326842 0.84 MMP2 (0.44) NOS2HTRA1NOS3NOS1EGFR
SCHEMBL7316571 0.84 MMP2 (0.44) NOS2HTRA1NOS3NOS1EGFR
Trifluoroacetic Acid SCHEMBL7326606 0.84 HTRA1 (0.43) NOS2HTRA1NOS3NOS1EED
SCHEMBL7326943 0.84 MMP2 (0.44) NOS2HTRA1NOS3NOS1EGFR
SCHEMBL7329506 0.83 NOS2 (0.40) NOS2HTRA1HDAC1EGFR
SCHEMBL22994397 0.83 NOS2 (0.56) TDP1ALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL3161145 0.83 NOS2 (0.56) TDP1ALDH1A1CYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5086069-A Platelet anticoagulants for blood and cardiovascular disorder RORER PHARMACEUTICAL CORPORATION (US) 1992-02-04 US disclosed